Literature DB >> 1384265

Putative mechanisms of action of tacrine in Alzheimer's disease.

A Adem1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384265     DOI: 10.1111/j.1600-0404.1992.tb04458.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


× No keyword cloud information.
  8 in total

1.  Characteristics of the binding of tacrine to acidic phospholipids.

Authors:  J Y Lehtonen; M Rytömaa; P K Kinnunen
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

2.  Interaction of tacrine and velnacrine with neocortical synaptosomal membranes: relevance to Alzheimer's disease.

Authors:  D A Butterfield; K Hensley; N Hall; S Umhauer; J Carney
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

3.  Effects of tacrine upon murine neuroblastoma cells.

Authors:  P Zatta; P Zambenedetti; M B Marturano; M Palumbo; M Nicolini
Journal:  J Neural Transm Gen Sect       Date:  1995

Review 4.  A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease.

Authors:  S C Samuels; K L Davis
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.228

5.  Phenotypic Displays of Cholinergic Enzymes Associate With Markers of Inflammation, Neurofibrillary Tangles, and Neurodegeneration in Pre- and Early Symptomatic Dementia Subjects.

Authors:  Unnur D Teitsdottir; Taher Darreh-Shori; Sigrun H Lund; Maria K Jonsdottir; Jon Snaedal; Petur H Petersen
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

6.  A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.

Authors:  Agneta Nordberg; Clive Ballard; Roger Bullock; Taher Darreh-Shori; Monique Somogyi
Journal:  Prim Care Companion CNS Disord       Date:  2013-03-07

Review 7.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

Review 8.  Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.

Authors:  Ondrej Soukup; Michael Winder; Uday Kumar Killi; Vladimir Wsol; Daniel Jun; Kamil Kuca; Gunnar Tobin
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.